SEC Form 4 · accession 0001209191-18-039689
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas S Ingram
Officer — President & CEO · Director
Period of report
Jun 26, 2018
Accepted (ET)
Jun 27, 2018 · 5:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 26, 2018 | F | 36,946 | $135.53 | D | 383,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.